Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.
暂无分享，去创建一个
E. Van Cutsem | F. Ciardiello | C. Köhne | G. Folprecht | S. Tejpar | M. Schlichting | P. Rougier | A. Zubel | D. Cunningham | I. Láng | J. Maurel | M. Nowacki | S. Cascinu | I. Shchepotin | I. Celik